Navigation Links
Arena Pharmaceuticals Announces Positive Lorcaserin Pivotal Phase 3 Obesity Trial Results: Meets All Primary Efficacy and Safety Endpoints
Date:3/30/2009

diabetes; future activities, results and announcements relating to lorcaserin, including the BLOSSOM results, the submission of an NDA for lorcaserin and the submission of the BLOOM-DM results as a supplement to the NDA; the potential of lorcaserin to meet the FDA's requirements for approval and the approval of lorcaserin for marketing; commercialization options and the coverage of lorcaserin patents; and about Arena's strategy, internal and partnered programs, and ability to develop compounds and commercialize drugs. For such statements, Arena claims the protection of the Private Securities Litigation Reform Act of 1995. Actual events or results may differ materially from Arena's expectations. Factors that could cause actual results to differ materially from the forward-looking statements include, but are not limited to, Arena's ability to obtain additional funds, the timing, success and cost of Arena's lorcaserin program and other of its research and development programs, the results of clinical trials or preclinical studies may not be predictive of future results, clinical trials and studies may not proceed at the time or in the manner Arena expects or at all, Arena's ability to partner lorcaserin or other of its compounds or programs, the timing and ability of Arena to receive regulatory approval for its drug candidates, Arena's ability to obtain and defend its patents, and the timing and receipt of payments and fees, if any, from Arena's collaborators. Additional factors that could cause actual results to differ materially from those stated or implied by Arena's forward-looking statements are disclosed in Arena's filings with the Securities and Exchange Commission. These forward-looking statements represent Arena's judgment as of the time of this release. Arena disclaims any intent or obligation to update these forward-looking statements, other than as may be required under applicable law.

    Contacts:   Jack Lief                          
'/>"/>
SOURCE Arena Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
2. Arena Pharmaceuticals Announces Public Offering of Common Stock
3. Arena Pharmaceuticals to Present at the BIOCOM Investor Conference
4. Arena Pharmaceuticals Announces Pricing of Public Offering of Common Stock
5. Arena Pharmaceuticals to Present at the Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
6. Arena Pharmaceuticals Lorcaserin for Obesity Passes Major Safety Milestone
7. Arena Pharmaceuticals to Present at the Morgan Stanley Global Healthcare Unplugged Conference
8. Arena Pharmaceuticals to Report First Quarter 2008 Financial Results and to Host Conference Call and Webcast on Wednesday, May 7, 2008
9. Field Poll: California Nurses Association Most Favorably Viewed Group in Healthcare Arena
10. Childrens Miracle Network and Arena Football League Partner for First Nationwide Celebration Event
11. Arena Pharmaceuticals Announces Third Quarter 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/6/2015)... Is Colorado’s legal cannabis industry the ... Centennial State will mark the 18-month milestone of its ... And while Colorado’s legal marijuana industry has been successful ... also facing some new challenges. , For example, many ... especially in the wake of last month’s “420” cannabis ...
(Date:5/6/2015)... (PRWEB) May 06, 2015 Inversion ... specializes in yoga and Pilates classes, provides personalized ... and products, starting with its new Pilates Ring ... effort of becoming leaner, stronger, more centered and ... offer a fresh venue to healthy fitness through ...
(Date:5/6/2015)... May 06, 2015 vcfo, a specialized ... IT and operational support to optimize business performance and ... Jack Lynch and Michael Scheaffer. Both Lynch and Scheaffer ... leadership experience. , “We are delighted to add ... vcfo CEO. “Leveraging their background in financial management and ...
(Date:5/6/2015)... Wolters Kluwer , a leading global ... today that in a survey of nearly 16,000 clinicians ... clinical decision support resource improves the quality of care ... users in more than 170 countries worldwide viewed more ... In Germany alone, 95% of all university hospitals use ...
(Date:5/6/2015)... 06, 2015 Anitoa Systems, (“Anitoa”), a ... Zhejiang University of China, has successfully demonstrated a handheld ... bio-optical sensor. Anitoa’s handheld qPCR is shown to ... and RNA’s, including hepatitis B, C, and E. Coli. ... copies per sample and over 9 orders of magnitude ...
Breaking Medicine News(10 mins):Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 2Health News:As Colorado Faces Regional Shortages, Cannabis CEO Says Marijuana Will Eventually Be Traded like Any Other Commodity 3Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 2Health News:Inversion Studios’ New Pilates Ring Is Circle of Magic for Body, Mind and Spirit 3Health News:vcfo Adds Two Senior Executives to Growing Team 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 2Health News:Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment 3Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 2Health News:Anitoa Systems Demonstrates Compact qPCR using Ultra Low-Light CMOS Bio-Optical Sensor 3
... ... with Telecity by signing a new £2m deal , ... (PRWEB) May 11, 2010 -- C4L, a leading UK colocation ... ensures the continuation of C4L’s long-term partnership with the Group, and enables the company to ...
... ... in the heart of downtown Coral Gables (Miami) Florida, Medical Equipment ... for over a decade. Their experts have a passion for ... http://www.medicalequipmentsolutions.com/rentals.html ) to hospital beds and oxygen concentrators, the specialists at ...
... ... Reconstructive, & Laser Surgery and Benjamin C. Stong MD are proud to be the first ... skin resurfacing technology. , ... May 11, 2010 -- Kalos: The Atlanta Center for Facial Plastic, Reconstructive, & Laser Surgery ...
... ... ... -- Is the primitive fear of being caught naked causing countless women to quit breastfeeding ... contributing to the public conversation about breastfeeding in an edgy new internet campaign that is ...
... participate in mild exercise programs led by physical therapists ... intensive care units (ICU) and hospitals than those who ... the April issue of the Archives of Physical ... project implemented in a medical intensive care unit at ...
... than physical abuse alone, study found , MONDAY, May 10 ... older women who are exposed to physical and verbal abuse ... show up in the results, study author Dr. Charles P. ... than physical abuse alone. , Why? "The physical abuse may ...
Cached Medicine News:Health News:Leading Colocation Provider C4L Signs 2M Deal with Telecitygroup 2Health News:Leading Colocation Provider C4L Signs 2M Deal with Telecitygroup 3Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 2Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 3Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 4Health News:Miami's Medical Equipment Solutions Now Offers Electric Power Wheelchair 5Health News:Kalos: Facial Plastic Surgery Brings the Pearl Fractional Laser to Atlanta 2Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 2Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 3Health News:Is Fear of Being Caught Naked an Obstacle to Increasing Breastfeeding Rates? 4Health News:Physical therapist-led exercise in patients in ICU improves function and decreases hospital stay 2Health News:Older, Abused Women Suffer Poor Mental Health 2
(Date:5/6/2015)... Calif. , May 6, 2015 ... biotechnology company in the emerging field of regenerative ... a meeting with the investment community to review ... cells) in spinal cord injury on Friday, May ... 1/2a clinical trial and future planned clinical activities ...
(Date:5/6/2015)... -- Delcath Systems, Inc. (NASDAQ: DCTH ), a ... with an emphasis on the treatment of primary and ... months ended March 31, 2015.  Highlights ... , Achieved quarterly product revenue of $0.44 million, an ... quarter of 2014; , Activated a prospective patient ...
(Date:5/6/2015)... 6, 2015 CVS Health (NYSE: CVS ) officially ... locations that sustained heavy fire damage during protests last ... Baltimore over the past week or so, our ... said CVS Health President and CEO Larry Merlo . "Our ... better health. There is no better way that we can fulfill ...
Breaking Medicine Technology:Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 2Asterias Biotherapeutics to Host Investor Meeting to Review Clinical Development Strategy for AST-OPC1 in Spinal Cord Injury 3Delcath Reports 2015 First Quarter Financial Results 2Delcath Reports 2015 First Quarter Financial Results 3Delcath Reports 2015 First Quarter Financial Results 4Delcath Reports 2015 First Quarter Financial Results 5Delcath Reports 2015 First Quarter Financial Results 6Delcath Reports 2015 First Quarter Financial Results 7Delcath Reports 2015 First Quarter Financial Results 8CVS Health Announces it Will Rebuild Baltimore CVS/pharmacy Locations 2
... Inc. (Nasdaq: ALXA ) today announced that company ... will present during the MDB Bright Lights Conference 2011.  The ... 10:00 a.m. Eastern Time.  The presentation will be webcast live ... via the Web, please go to the Investor Relations tab ...
... DIEGO, May 6, 2011 Arena Pharmaceuticals, Inc. (NASDAQ: ... to present at the Bank of America Merrill Lynch 2011 Health ... Time (1:00 p.m. Eastern Time) at the Encore at the Wynn ... Ph.D., Arena,s Vice President, Lorcaserin Development, is scheduled to provide a ...
Cached Medicine Technology:Alexza to Present at the MDB Bright Lights Conference 2011 2Alexza to Present at the MDB Bright Lights Conference 2011 3Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference 2Arena Pharmaceuticals to Present at the Bank of America Merrill Lynch 2011 Health Care Conference 3
... gel contains 10% Povidone Iodine USP, 1% ... a pre-operative prep, Povidone Iodine Gel helps ... under the patient, thus reducing the chance ... approved as a one step gel for ...
... Aplicare's Iodine Scrub is a gentle and ... to prevent dryness. Povidone Iodine is known ... and gram-positive bacteria, fungi, viruses, protozoa and ... the first step in patient pre-operative prepping, ...
... Aplicare two and four ... to meet the needs of ... The bottle itself has been ... to match the cap perfectly. ...
A patient skin prepping solution in a self-contained applicator combining two proven broad-spectrum antimicrobials: alcohol for fast kill and fast drying (3 minutes on skin), and an iodophor for pers...
Medicine Products: